VILIN BIO MED LIMITED

VILINBIO

Small Cap | Pharmaceuticals
₹47.5
-0.09 (-0.18%)

Stock price as on 26 May 2026 at 10:15 AM

Vilin bio med limited share price update

As of the latest trading session, Vilin Bio Med Limited share price is currently at ₹47.5, which is down by ₹-0.09 from its previous closing. Today th...

Vilin Bio Med Limited stock performance

Today’s low

₹47.5

Today’s high

₹47.5

₹47.5

52 week low

₹18.95

52 week high

₹54.4

₹47.5
Open
₹47.50
Previous close
₹47.60
Share volume
4,000
Total traded value (Lakh)
₹1.90
Upper circuit
₹48.55
Lower circuit
₹46.65

Vilin Bio Med Limited fundamentals

Market cap (Cr)
₹72.40
P/E ratio (TTM)
317.33
Book value per share
₹17.34
Beta
-0.15
Return on equity
0.96%
Earnings per share (TTM)
₹0.15
Dividend yield
0%
Net profit/quarter (Cr)
-₹0.04

Vilin Bio Med Limited technical summary

₹47.5
-0.21 ▼
2
Bearish
14
Bullish
5 Day48
10 Day46.2
12 Day45.5
20 Day43.3
26 Day42.1
50 Day38.7
100 Day34.5
200 Day30.5
5 Day49.4
10 Day46.1
12 Day44.7
20 Day41.8
26 Day40.8
50 Day37.9
100 Day32
200 Day29.2

48.5

PIVOT

First support
₹48.50
First resistance
₹48.50
Second support
₹48.50
Second resistance
₹48.50
Third support
₹48.50
Third resistance
₹48.50
RSI
71.31
ADX
37.4
MACD
3.51
Williams % R
-33.33
Commodity Channel Index (CCI)
106.84
Date
12 May 2026
Same day
36,000
Week
34,667
Month
18,667
1 year
-0.14
3 years
0.17
Over 1 month
31.08%
Over 1 year
82.67%
Over 3 months
44.13%
Over 3 years
19.38%
Over 6 months
114.12%
Over 6 years
0%

Investment Returns

Over 1 Month31.08%
Over 3 Months44.13%
Over 6 Months114.12%
Over 1 Year82.67%

Vilin Bio Med Limited Shareholding pattern


Public
40.43%
Promoter holdings
59.56%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Shankar Reddy Katireddy

17,80,520 (11.68%)

Shareholding of Promoter and Promoter Group

Srinivasa Reddy Devireddy

17,60,838 (11.55%)

Shareholding of Promoter and Promoter Group

Pravallika Venna

13,35,400 (8.76%)

Shareholding of Promoter and Promoter Group

Allu Ramakrishna Reddy

11,12,830 (7.3%)

Shareholding of Promoter and Promoter Group

Julakanti Naga Avinash Reddy

8,90,260 (5.84%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Shankar Reddy Katireddy17,80,520 (11.68%)Shareholding of Promoter and Promoter Group
Srinivasa Reddy Devireddy17,60,838 (11.55%)Shareholding of Promoter and Promoter Group
Pravallika Venna13,35,400 (8.76%)Shareholding of Promoter and Promoter Group
Allu Ramakrishna Reddy11,12,830 (7.3%)Shareholding of Promoter and Promoter Group
Julakanti Naga Avinash Reddy8,90,260 (5.84%)Shareholding of Promoter and Promoter Group
Enspire Institute Of Professional Studies Llp6,70,000 (4.39%)Public Shareholding
Amn Ventures Llp6,30,000 (4.13%)Public Shareholding
Percy Homi Italia5,98,000 (3.92%)Public Shareholding
Sharaz Shaik5,13,075 (3.36%)Shareholding of Promoter and Promoter Group
Mohan Rao Adhi5,05,130 (3.31%)Shareholding of Promoter and Promoter Group
Ramesh Reddy Sama4,63,234 (3.04%)Shareholding of Promoter and Promoter Group
Jwala Veeravenkata Panduranga Praneeth4,45,130 (2.92%)Shareholding of Promoter and Promoter Group
Krishna4,36,000 (2.86%)Public Shareholding
Karunakar Reddy Kundoor2,07,957 (1.36%)Shareholding of Promoter and Promoter Group
Sudhanshu Kanda1,60,000 (1.05%)Public Shareholding
Tanmayee Reddy Sama21,250 (0.14%)Shareholding of Promoter and Promoter Group
Ramiza Shaik20,000 (0.13%)Shareholding of Promoter and Promoter Group
Anuj Bajpai15,000 (0.1%)Shareholding of Promoter and Promoter Group
Sneh Bajpai9,375 (0.06%)Shareholding of Promoter and Promoter Group
Shaik Saraf4,000 (0.03%)Shareholding of Promoter and Promoter Group

About VILIN BIO MED LIMITED

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The Company started its first commercial production in 2006. In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections. In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactu

Parent Organisation

Indian Private

NSE Symbol

VILINBIO

Founded

2005

VILIN BIO MED LIMITED CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

DECNGOLD

DECCAN GOLD MINES LTD.

177.6
+29.6 (+20%)
ASHCAP

ASHIRWAD CAPITAL LTD.

3.3
+0.55 (+20%)
MODISONLTD

MODISON LIMITED

251.13
+41.85 (+20%)
BLISSGVS

BLISS GVS PHARMA LTD

381.05
+63.5 (+20%)
View all

Top gainers

ADANIENT

ADANI ENTERPRISES LIMITED

2969.3
+119.60 (+4.20%)
TMPV

TATA MOTORS PASS VEH LTD

385.6
+12.35 (+3.31%)
TECHM

TECH MAHINDRA LIMITED

1458.7
+23.20 (+1.62%)
NESTLEIND

NESTLE INDIA LIMITED

1428.6
+15.00 (+1.06%)
View all

Top losers

APOLLOHOSP

APOLLO HOSPITALS ENTER. L

8258.5
-145.50 (-1.73%)
WIPRO

WIPRO LTD

203.73
-3.11 (-1.50%)
BHARTIARTL

BHARTI AIRTEL LIMITED

1846.9
-27.90 (-1.49%)
TRENT

TRENT LTD

4239.6
-60.40 (-1.40%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)